(Total Views: 909)
Posted On: 06/02/2019 8:00:57 PM
Post# of 102
https://www.amazon.com/Nyloxin/b/ref=bl_dp_s_...in=Nyloxin
Bought more Nyloxin on Amazon in May 2019. Ships fast and works on pain from titanium plates screwed into your bones
https://twitter.com/nyloxin
News 5/30/2019 New medical supply DC
https://www.globenewswire.com/news-release/20...place.html
New distributor looks good https://iremedy.com/portfolio/
iRemedy
NPHC
https://www.nutrapharma.com/pharmaceuticals HIV MS Medicine
RPI-78M has received Orphan Drug Designation from the FDA for the treatment of Pediatric Multiple Sclerosis
https://multiplesclerosisnewstoday.com/rpi-78m
The Company has two leading biopharmaceutical products: RPI-MN and RPI-78M.
RPI-MN inhibits the entry of several viruses that are known to cause severe neurological damage in such diseases as encephalitis and Human Immunodeficiency Virus (HIV). It is being developed first for the treatment of HIV.
RPI-78M is being developed for the treatment of Multiple Sclerosis (MS) and Adrenomyeloneuropathy (AMN). Other neurological disorders that may be served by RPI-78M include Myasthenia Gravis (MG) and Amyotrophic Lateral Sclerosis (ALS).
https://www.consumerhealthdigest.com/topical-...nt=Nyloxin
https://www.amazon.com/Nyloxin-Topical-Gel-Ro...amp;sr=8-5
Bought more Nyloxin on Amazon in May 2019. Ships fast and works on pain from titanium plates screwed into your bones
https://twitter.com/nyloxin
News 5/30/2019 New medical supply DC
https://www.globenewswire.com/news-release/20...place.html
New distributor looks good https://iremedy.com/portfolio/
iRemedy
NPHC
https://www.nutrapharma.com/pharmaceuticals HIV MS Medicine
RPI-78M has received Orphan Drug Designation from the FDA for the treatment of Pediatric Multiple Sclerosis
https://multiplesclerosisnewstoday.com/rpi-78m
The Company has two leading biopharmaceutical products: RPI-MN and RPI-78M.
RPI-MN inhibits the entry of several viruses that are known to cause severe neurological damage in such diseases as encephalitis and Human Immunodeficiency Virus (HIV). It is being developed first for the treatment of HIV.
RPI-78M is being developed for the treatment of Multiple Sclerosis (MS) and Adrenomyeloneuropathy (AMN). Other neurological disorders that may be served by RPI-78M include Myasthenia Gravis (MG) and Amyotrophic Lateral Sclerosis (ALS).
https://www.consumerhealthdigest.com/topical-...nt=Nyloxin
https://www.amazon.com/Nyloxin-Topical-Gel-Ro...amp;sr=8-5
(0)
(0)
[img]montrealgotstyle.com/wp-content/uploads/2017/09/pker.gif[/img]
HPMM PCLI ZMRK OXIHF IKTO VGLS RMRK APRU NWPN SNRY MEDH
HPMM PCLI ZMRK OXIHF IKTO VGLS RMRK APRU NWPN SNRY MEDH
Scroll down for more posts ▼